Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald McMillan

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer Medicine|May 18, 2023
High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patientsElizabeth Morrow, Kathryn Pennel, Phimmada Hatthakarnkul, et al.
Biomolecules|January 8, 2025
IL6 and IL6R as Prognostic Biomarkers in Colorectal CancerKathryn A F Pennel, Ahmad Kurniawan, Sara Samir Foad Al-Badran, et al.
The Journal of Pathology. Clinical Research|April 23, 2024
Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancerPhimmada Hatthakarnkul, Kathryn Pennel, Peter Alexander, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 24, 2024
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint seriesMichael S Yule, Joshua Thompson, Khachonphat Leesahatsawat, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 6, 2023
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints seriesJames McDonald, Judith Sayers, Stefan D Anker, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer Medicine|May 18, 2023
High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patientsElizabeth Morrow, Kathryn Pennel, Phimmada Hatthakarnkul, et al.
Biomolecules|January 8, 2025
IL6 and IL6R as Prognostic Biomarkers in Colorectal CancerKathryn A F Pennel, Ahmad Kurniawan, Sara Samir Foad Al-Badran, et al.
The Journal of Pathology. Clinical Research|April 23, 2024
Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancerPhimmada Hatthakarnkul, Kathryn Pennel, Peter Alexander, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 24, 2024
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint seriesMichael S Yule, Joshua Thompson, Khachonphat Leesahatsawat, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 6, 2023
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints seriesJames McDonald, Judith Sayers, Stefan D Anker, et al.
Pageof 2